[go: up one dir, main page]

MX2009008991A - Amorphous solid composition containing a pyrazole-3-carboxamide in amorphous form and stabilising carriers. - Google Patents

Amorphous solid composition containing a pyrazole-3-carboxamide in amorphous form and stabilising carriers.

Info

Publication number
MX2009008991A
MX2009008991A MX2009008991A MX2009008991A MX2009008991A MX 2009008991 A MX2009008991 A MX 2009008991A MX 2009008991 A MX2009008991 A MX 2009008991A MX 2009008991 A MX2009008991 A MX 2009008991A MX 2009008991 A MX2009008991 A MX 2009008991A
Authority
MX
Mexico
Prior art keywords
carboxamide
pyrazole
amorphous
composition containing
solid composition
Prior art date
Application number
MX2009008991A
Other languages
Spanish (es)
Inventor
Jean Alie
Jerome Menegotto
Michel Bauer
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of MX2009008991A publication Critical patent/MX2009008991A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

The invention relates to a pyrazole-3-carboxamide in amorphous form, to an amorphous solid solution containing the same, and more generally to pharmaceutical composition containing the same.
MX2009008991A 2007-02-23 2008-02-20 Amorphous solid composition containing a pyrazole-3-carboxamide in amorphous form and stabilising carriers. MX2009008991A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0701377A FR2913018A1 (en) 2007-02-23 2007-02-23 New pyrazol-3-carboxamide derivative in amorphous form comprising surinabant and rimonabant form, useful for preparing amorphous solid solution
PCT/FR2008/000216 WO2008129157A2 (en) 2007-02-23 2008-02-20 Amorphous solid composition containing a pyrazole-3-carboxamide in amorphous form and stabilising carriers

Publications (1)

Publication Number Publication Date
MX2009008991A true MX2009008991A (en) 2009-09-03

Family

ID=38561793

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009008991A MX2009008991A (en) 2007-02-23 2008-02-20 Amorphous solid composition containing a pyrazole-3-carboxamide in amorphous form and stabilising carriers.

Country Status (20)

Country Link
US (1) US20100076023A1 (en)
EP (1) EP2132182A2 (en)
JP (1) JP2010519246A (en)
KR (1) KR20090113305A (en)
CN (1) CN101641333A (en)
AR (1) AR065410A1 (en)
AU (1) AU2008240507A1 (en)
BR (1) BRPI0807575A2 (en)
CA (1) CA2678801A1 (en)
CL (1) CL2008000550A1 (en)
CO (1) CO6210812A2 (en)
EA (1) EA200970792A1 (en)
FR (1) FR2913018A1 (en)
IL (1) IL200370A0 (en)
MA (1) MA31244B1 (en)
MX (1) MX2009008991A (en)
PE (1) PE20081778A1 (en)
TW (1) TW200846339A (en)
UY (1) UY30937A1 (en)
WO (1) WO2008129157A2 (en)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2713225B1 (en) * 1993-12-02 1996-03-01 Sanofi Sa Substituted N-piperidino-3-pyrazolecarboxamide.
FR2761266B1 (en) * 1997-03-28 1999-07-02 Sanofi Sa PHARMACEUTICAL COMPOSITION FORMED BY WET GRANULATION FOR THE ORAL ADMINISTRATION OF A DERIVATIVE OF N-PIPERIDINO-3- PYRAZOLECARBOXAMIDE, ITS SALTS AND THEIR SOLVATES
FR2789079B3 (en) * 1999-02-01 2001-03-02 Sanofi Synthelabo PYRAZOLECARBOXYLIC ACID DERIVATIVE, ITS PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
GB0216700D0 (en) * 2002-07-18 2002-08-28 Astrazeneca Ab Process
FR2873372B1 (en) * 2004-07-22 2006-09-08 Sanofi Synthelabo PROCESS FOR THE PREPARATION OF N-PIPERIDINO-1,5-DIPHENYLPYRAZOLE-3-CARBOXAMIDE DERIVATIVES
EP1844017A1 (en) * 2005-01-06 2007-10-17 Cadila Healthcare Ltd. An amorphous and three crystalline forms of rimonabant hydrochloride
AR052660A1 (en) * 2005-01-21 2007-03-28 Astex Therapeutics Ltd PIRAZOL DERIVATIVES TO INHIBIT THE CDK'S AND GSK'S
KR100678824B1 (en) * 2005-02-04 2007-02-05 한미약품 주식회사 Amorphous tacrolimus solid dispersion with increased solubility and pharmaceutical composition comprising the same
DE102005026755A1 (en) * 2005-06-09 2006-12-14 Basf Ag Production of solid solutions of sparingly soluble active ingredients by short-term overheating and rapid drying
EP1816125A1 (en) * 2006-02-02 2007-08-08 Ranbaxy Laboratories, Ltd. Novel crystalline forms of an antagonist of CB1 cannabinoid receptor and preparation method thereof
WO2007103711A2 (en) * 2006-03-01 2007-09-13 Dr. Reddy's Laboratories Ltd. Polymorphic forms of rimonabant
US8431609B2 (en) * 2007-02-19 2013-04-30 Darmesh Mahendrabhai Shah Process for preparation of pyrazole derivatives

Also Published As

Publication number Publication date
WO2008129157A3 (en) 2008-12-31
KR20090113305A (en) 2009-10-29
IL200370A0 (en) 2010-04-29
AU2008240507A1 (en) 2008-10-30
BRPI0807575A2 (en) 2014-07-01
WO2008129157A2 (en) 2008-10-30
WO2008129157A4 (en) 2009-03-05
CL2008000550A1 (en) 2008-07-04
CA2678801A1 (en) 2008-10-30
AR065410A1 (en) 2009-06-03
US20100076023A1 (en) 2010-03-25
EP2132182A2 (en) 2009-12-16
CO6210812A2 (en) 2010-10-20
MA31244B1 (en) 2010-03-01
UY30937A1 (en) 2008-09-30
PE20081778A1 (en) 2009-01-01
EA200970792A1 (en) 2010-04-30
CN101641333A (en) 2010-02-03
FR2913018A1 (en) 2008-08-29
TW200846339A (en) 2008-12-01
JP2010519246A (en) 2010-06-03

Similar Documents

Publication Publication Date Title
PH12017502300A1 (en) Pesticidal compositions and processes related thereto
MX2010006143A (en) Azolylmethyloxiranes, use thereof and agents containing the same.
SI2203439T1 (en) 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h, 1'h-y1, 4' bipyridinyl-2'-ones
IL205880A0 (en) Aminoglycoside analogs, compositions comprising the same and uses thereof
GB2460579A (en) Silylethynylated heteroacenes and electronic devices made therewith
EP2488601A4 (en) Electrochromic compound, electrochromic composition, and display element
IL212836A0 (en) Azaquinolinone derivatives, compositions comprising the same and uses thereof
IL212278A0 (en) Morpholinopurine derivatives, compositions comprising the same and uses thereof
WO2009077500A3 (en) Azolylmethyloxiranes, use thereof and agents containing the same
IL206808A (en) Indolyl-pyridone derivatives, pharmaceutical compositions comprising the same and uses thereof
UA96596C2 (en) IMPROVED DISPENSING DEVICE$IMPROVED FEEDING DEVICE
MX2010002028A (en) Methods and compositions for modulating t cells.
PT2356989T (en) Stable tablet containing 4,5-epoxymorphinan derivative
GB2461659A (en) Structured compositions comprising a clay
CO6241120A2 (en) (DIHIDRO) PIRROLO [2,1-á] ISOQUINOLINAS.
MX2007011048A (en) Stable organic peroxide compositions.
GB0613208D0 (en) Compounds
MY149433A (en) Nutritional compositions containing punicalagins
UA96476C2 (en) Pharmaceutical composition comprising irbesartan
ZA200903193B (en) Novel Morphine derivatives
PL2176282T3 (en) 8-beta-substituted 16.alpha.-fluoro-estratrienes as selectively active estrogens
MX2009008991A (en) Amorphous solid composition containing a pyrazole-3-carboxamide in amorphous form and stabilising carriers.
ZA201005396B (en) 17-hydroxy-19-nor-21-carboxylic acid-steroid y-lactone derivative,use thereof,and medicament containing the derivative
AU311666S (en) Wine rack
AU311667S (en) Wine rack

Legal Events

Date Code Title Description
FA Abandonment or withdrawal